M. Simard

发表

Cytokine Kinetics and Other Host Factors in Response to Pneumococcal Pulmonary Infection in Mice

M. Bergeron, M. Olivier, Y. Bergeron, 1998, Infection and Immunity.

Infection in Mice Response to Pneumococcal Pulmonary Cytokine Kinetics and Other Host Factors in

M. Bergeron, A. Deslauriers, M. Olivier, 1998 .

In Vivo Activity and Pharmacokinetics of Ziracin (SCH27899), a New Long-Acting Everninomicin Antibiotic, in a Murine Model of Penicillin-Susceptible or Penicillin-Resistant Pneumococcal Pneumonia

M. Bergeron, Y. Bergeron, M. Simard, 2000, Antimicrobial Agents and Chemotherapy.

HIV-1 Nef Disrupts Maturation of CD4+ T Cells through CD4/Lck Modulation

P. Chrobak, P. Jolicoeur, M. Simard, 2010, The Journal of Immunology.

Kinetic study of host defense and inflammatory response to Aspergillus fumigatus in steroid-induced immunosuppressed mice.

M. Bergeron, M. Olivier, Y. Bergeron, 1998, The Journal of infectious diseases.

Cardiac Disease in HIV-1 Tg Animals

P. Jolicoeur, M. Simard, D. Kay, 2004 .

Kinetic Study of the Inflammatory Response in Streptococcus pneumoniae Experimental Pneumonia Treated with the Ketolide HMR 3004

M. Bergeron, Y. Bergeron, M. Simard, 2001, Antimicrobial Agents and Chemotherapy.

Local production of inflammatory mediators in an experimental model of acute obstructive pyelonephritis.

M. Bergeron, M. Simard, A. Kabore, 1999, The Journal of infectious diseases.

Daptomycin may attenuate experimental tobramycin nephrotoxicity by electrostatic complexation to tobramycin

M. Bergeron, D. Carrier, M. Simard, 1994, Antimicrobial Agents and Chemotherapy.

Subcellular localization of tobramycin and vancomycin given alone and in combination in proximal tubular cells, determined by immunogold labeling

M. Bergeron, M. Simard, D. Beauchamp, 1992, Antimicrobial Agents and Chemotherapy.

Protein-rich diet attenuates cyclosporin A-induced renal tubular damage in rats.

I. Plante, M. Simard, L. Grenier, 2003, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

Protection against gentamicin nephrotoxicity by daptomycin in nephrectomized rats.

M. Bergeron, M. Simard, L. Grenier, 1995, Life sciences.

Attenuation by daptomycin of gentamicin-induced experimental nephrotoxicity

M. Bergeron, M. Simard, L. Grenier, 1994, Antimicrobial Agents and Chemotherapy.

Subcellular distribution of daptomycin given alone or with tobramycin in renal proximal tubular cells

M. Bergeron, M. Simard, D. Beauchamp, 1994, Antimicrobial Agents and Chemotherapy.

Immunomodulating Effects of HMR 3004 on Pulmonary Inflammation Caused by Heat-Killed Streptococcus pneumoniae in Mice

M. Bergeron, Y. Bergeron, N. Ouellet, 1998, Antimicrobial Agents and Chemotherapy.

Reduction by Cefodizime of the Pulmonary Inflammatory Response Induced by Heat-Killed Streptococcus pneumoniae in Mice

M. Bergeron, M. Olivier, Y. Bergeron, 1998, Antimicrobial Agents and Chemotherapy.

Pulmonary and Systemic Host Response to Streptococcus pneumoniae and Klebsiella pneumoniae Bacteremia in Normal and Immunosuppressed Mice

M. Bergeron, Y. Bergeron, N. Ouellet, 2001, Infection and Immunity.

Pathogenesis of Pneumococcal Pneumonia in Cyclophosphamide-Induced Leukopenia in Mice

M. Bergeron, Y. Bergeron, N. Ouellet, 2002, Infection and Immunity.

Microbiological and inflammatory factors associated with the development of pneumococcal pneumonia.

M. Bergeron, Y. Bergeron, N. Ouellet, 2001, The Journal of infectious diseases.

Temporal variation in nephrotoxicity of low doses of isepamicin in rats

M. Bergeron, M. Simard, L. Grenier, 1996, Antimicrobial agents and chemotherapy.

Temporal changes of pharmacokinetics, nephrotoxicity, and subcellular distribution of tobramycin in rats

M. Bergeron, Y. Bergeron, M. Simard, 1994, Antimicrobial Agents and Chemotherapy.

Expression of Simian Immunodeficiency Virus nef in Immune Cells of Transgenic Mice Leads to a Severe AIDS-Like Disease

P. Chrobak, P. Jolicoeur, M. Simard, 2002, Journal of Virology.

Differential distributions in tissues and efficacies of aztreonam and ceftazidime and in vivo bacterial morphological changes following treatment

M. Bergeron, M. Simard, D. Beauchamp, 1997, Antimicrobial agents and chemotherapy.

Modulation of cytokines and chemokines, limited pulmonary vascular bed permeability, and prevention of septicemia and death with ceftriaxone and interleukin-10 in pneumococcal pneumonia.

M. Bergeron, Y. Bergeron, N. Ouellet, 2000, The Journal of infectious diseases.

Role of Chemokines and Formyl Peptides in Pneumococcal Pneumonia-Induced Monocyte/Macrophage Recruitment2

M. Bergeron, Y. Bergeron, N. Ouellet, 2001, The Journal of Immunology.

Monocyte / Macrophage Recruitment Pneumococcal Pneumonia-Induced Role of Chemokines and Formyl Peptides in Bergeron

M. Bergeron, N. Ouellet, M. Simard, 2001 .

In Pathogenicity in Transgenic Mice Type 1 Nef Alleles Show Major Differences Primary Human Immunodeficiency Virus

F. Kirchhoff, P. Vincent, M. Schindler, 2022 .

Role of Galectin-3 as an Adhesion Molecule for Neutrophil Extravasation During Streptococcal Pneumonia1

M. Bergeron, A. Rancourt, I. Pelletier, 2002, The Journal of Immunology.

Efficacy of recombinant human granulocyte colony-stimulating factor in a murine model of pneumococcal pneumonia: effects of lung inflammation and timing of treatment.

M. Bergeron, F. Dallaire, Y. Bergeron, 2001, The Journal of infectious diseases.

Ribavirin potentiates the efficacy and toxicity of 2',3'- dideoxyinosine in the murine acquired immunodeficiency syndrome model.

M. Bergeron, M. Tremblay, P. Harvie, 1996, The Journal of pharmacology and experimental therapeutics.

Immunomodulation of Pneumococcal Pulmonary Infection withNG-Monomethyl-l-Arginine

M. Bergeron, M. Olivier, Y. Bergeron, 1999, Antimicrobial Agents and Chemotherapy.

Primary Human Immunodeficiency Virus Type 1 Nef Alleles Show Major Differences in Pathogenicity in Transgenic Mice

F. Kirchhoff, P. Vincent, M. Schindler, 2007, Journal of Virology.